Kewaunee Scientific Corporation KEQU
34.02
(0.26)
(0.76%)
as of 25 Sep
- Market cap
- $99.3M
- P/E
- 11.9×
Follow KEQU
Growth Flags
show if company had growth for consecutive years
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
17.74% | 16.46% | 13.45% | 11.27% | |
| 7.26% | 6.07% | 5.16% | 4.46% | ||
ROIC |
10.25% | 11.34% | 9.34% | 8.40% | |
Return on Tangible Assets |
12.91% | 14.31% | 12.11% | 10.47% | |
Average Days of Receivables |
75.45 | 68.66 | 76.03 | 76.63 | |
Free Cash Flow per Share |
1.79 | 6.65 | 5.13 | 3.78 | |
Free Cash Flow |
5.12 | 19.06 | 14.70 | 10.88 | |
Capital Expenditures |
(3.55) | (3.52) | (3.94) | (3.94) | |
Piotroski F-Score |
4.00 | 5.00 | 5.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
5.88% | 17.25% | 13.80% | 11.17% | |
Accounts Receivable Turnover |
5.66 | 5.16 | 4.66 | 4.82 | |
Accounts Payable Turnover |
9.18 | 8.49 | 8.15 | 8.27 | |
Inventory Turnover |
7.48 | 6.34 | 6.36 | 6.12 | |
Average Days of Payables |
40.85 | 42.19 | 40.66 | 39.73 | |
Days of Inventory on Hand |
64.00 | 58.73 | 55.29 | 54.89 | |
Tax Rate |
(0.24) | (0.27) | (0.24) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.64% | 0.69% | 0.75% | 1.26% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.74 | 2.04 | 1.94 | 1.80 | |
Depreciation/Fixed assets |
0.29 | 0.31 | 0.31 | 0.31 | |
Capex/Depreciation |
(0.53) | (0.50) | (0.57) | (0.57) | |
Revenue per Share |
99.62 | 100.40 | 98.50 | 96.26 | |
Operating CF per Share |
3.02 | 7.88 | 6.51 | 5.15 | |
Capex per Share |
(1.24) | (1.23) | (1.38) | (1.37) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
4.11% | 3.85% | 3.41% | 2.97% |
Columns are period end dates